Bolt Biotherapeutics (BOLT) Shares Outstanding (2020 - 2026)

Bolt Biotherapeutics has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $1.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.24% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed 0.24% YoY) and the FY2025 annual result came in at $1.9 million, changed 0.19% from the prior year.
• Shares Outstanding (Entity) was little changed at $1.9 million in Q1 2026 per BOLT's latest filing, from $1.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.9 million in Q1 2026 and troughed at $1.9 million in Q1 2022.
• A 5-year average of $1.9 million and a median of $1.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 74.23% in 2022, then climbed 0.19% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $1.9 million in 2022, then advanced by 0.84% to $1.9 million in 2023, then climbed by 0.59% to $1.9 million in 2024, then rose by 0.19% to $1.9 million in 2025, then rose by 0.05% to $1.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.9 million, $1.9 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.